BACK4 Safety Evaluation
Safety Evaluation of BACK4 Device
1 other identifier
interventional
24
1 country
1
Brief Summary
To characterize the safety of combined RF and EMS therapies with the BACK4 device in healthy volunteers. Subjects will receive 3 treatments of increasing intensity over a one week period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2025
CompletedFirst Posted
Study publicly available on registry
September 4, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2025
CompletedJanuary 2, 2026
December 1, 2025
2 months
August 26, 2025
December 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with a reported Adverse Event
Characterize the number of adverse events for the combined use of RF and EMS with the BACK4 device across the device's intended configurations
7 days
Secondary Outcomes (2)
Number of participants with a device-related adverse event
7 days
Number of patients reporting therapy tolerability
7 days
Study Arms (2)
Hands-on
ACTIVE COMPARATORTreatment delivered by therapist utilizing multipolar electrode
Hands-free
ACTIVE COMPARATORTreatment delivered utilizing fixed pads
Interventions
Use of combined RF and EMS therapy with BACK4 Device
Eligibility Criteria
You may qualify if:
- Adults 22-55 years old
- Able to provide written informed consent
You may not qualify if:
- Injury within the past 30 days
- Cancer or cancerous lesions in the treatment area
- Skin disorders (e.g., eczema, shingles), skin burns, or open wounds
- Coagulation disorders, phlebitis, or thrombophlebitis
- Insensitivity to heat
- Local insensitivity to pain and/or touch
- Fever, bacterial infection, infectious disease, or tuberculosis
- Severe hypertension or hypotension
- Electrical implants (e.g., pacemaker, insulin pump, neurostimulator)
- History of seizures or recent surgery
- Known hypersensitivity to device materials
- Pregnant or breastfeeding women
- Participation in another clinical trial within 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
RORE Method
Birmingham, Michigan, 48009, United States
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2025
First Posted
September 4, 2025
Study Start
October 1, 2025
Primary Completion
November 30, 2025
Study Completion
December 25, 2025
Last Updated
January 2, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share